Hofbauer细胞与妊娠期COVID-19的胎盘病理
该研究回顾性分析7国22例SARS-CoV-2感染孕妇的胎盘,用分子病理方法检测Hofbauer细胞等胎儿来源细胞的病毒累及。所有胎盘均有慢性组织细胞性绒毛间隙炎和滋养细胞坏死;4例(18.2%)Hofbauer细胞SARS-CoV-2阳性,2例(9.1%)绒毛毛细血管内皮阳性,21例(95.5%)合体滋养细胞阳性。结论:SARS-CoV-2可延伸至绒毛基质累及Hofbauer细胞和内皮细胞,但多数经胎盘胎儿感染不伴Hofbauer细胞累及。
要点
- 所有22例感染胎盘均见慢性组织细胞性绒毛间隙炎和滋养细胞坏死。
- 仅4例(18.2%)Hofbauer细胞SARS-CoV-2阳性,2例(9.1%)绒毛毛细血管内皮阳性。
- 7例确诊经胎盘胎儿感染中,仅2例(28.6%)胎盘Hofbauer细胞阳性。
核心结论
- SARS-CoV-2可超越滋养细胞进入绒毛基质,累及Hofbauer细胞和毛细血管内皮细胞,但仅见于少数感染胎盘。
- 多数SARS-CoV-2经胎盘胎儿感染发生时并无Hofbauer细胞累及。
研究设计与样本
- 基于病例的回顾性分析,由29名围产期和分子病理学专家对来自7个国家的22例SARS-CoV-2感染孕妇胎盘进行 preselected 队列分析。
- 采用分子病理学方法检测Hofbauer细胞、绒毛毛细血管内皮、合体滋养细胞及其他胎儿来源细胞的病毒累及。
主要发现
- 慢性组织细胞性绒毛间隙炎和滋养细胞坏死存在于全部22例胎盘(100%)。
- Hofbauer细胞SARS-CoV-2阳性见于4/22例胎盘(18.2%)。
- 绒毛毛细血管内皮阳性见于2/22例(9.1%),两例同时有Hofbauer细胞病毒阳性。
- 合体滋养细胞阳性见于21/22例胎盘(95.5%)。
- Hofbauer细胞增生见于3/22例胎盘(13.6%);7例有记录的经胎盘胎儿感染中,2例(28.6%)发生于Hofbauer细胞SARS-CoV-2阳性的胎盘。
临床怎么用
- 胎盘病理评估SARS-CoV-2感染时,应关注慢性组织细胞性绒毛间隙炎和滋养细胞坏死。
- Hofbauer细胞和毛细血管内皮病毒累及仅见于少数病例,不能作为经胎盘胎儿感染的必备指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT.—: SARS-CoV-2 can undergo maternal-fetal transmission, heightening interest in the placental pathology findings from this infection. Transplacental SARS-CoV-2 transmission is typically accompanied by chronic histiocytic intervillositis together with necrosis and positivity of syncytiotrophoblast for SARS-CoV-2. Hofbauer cells are placental macrophages that have been involved in viral diseases, including HIV and Zika virus, but their involvement in SARS-CoV-2 is unknown. OBJECTIVE.—: To determine whether SARS-CoV-2 can extend beyond the syncytiotrophoblast to enter Hofbauer cells, endothelium, and other villous stromal cells in infected placentas of liveborn and stillborn infants. DESIGN.—: Case-based retrospective analysis by 29 perinatal and molecular pathology specialists of placental findings from a preselected cohort of 22 SARS-CoV-2-infected placentas delivered to pregnant women testing positive for SARS-CoV-2 from 7 countries. Molecular pathology methods were used to investigate viral involvement of Hofbauer cells, villous capillary endothelium, syncytiotrophoblast, and other fetal-derived cells. RESULTS.—: Chronic histiocytic intervillositis and trophoblast necrosis were present in all 22 placentas (100%). SARS-CoV-2 was identified in Hofbauer cells from 4 of 22 placentas (18.2%). Villous capillary endothelial staining was positive in 2 of 22 cases (9.1%), both of which also had viral positivity in Hofbauer cells. Syncytiotrophoblast staining occurred in 21 of 22 placentas (95.5%). Hofbauer cell hyperplasia was present in 3 of 22 placentas (13.6%). In the 7 cases having documented transplacental infection of the fetus, 2 (28.6%) occurred in placentas with Hofbauer cell staining positive for SARS-CoV-2. CONCLUSIONS.—: SARS-CoV-2 can extend beyond the trophoblast into the villous stroma, involving Hofbauer cells and capillary endothelial cells, in a small number of infected placentas. Most cases of SARS-CoV-2 transplacental fetal infection occur without Hofbauer cell involvement.
引用
- Schwartz DA, Baldewijns M, Benachi A, et al. Hofbauer Cells and COVID-19 in Pregnancy. Arch Pathol Lab Med. 2021. PMID: 34297794. doi:10.5858/arpa.2021-0296-SA
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。